➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
AstraZeneca
Medtronic
Mallinckrodt
Colorcon

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

ALKINDI SPRINKLE Drug Profile


Email this page to a colleague

« Back to Dashboard

When do Alkindi Sprinkle patents expire, and when can generic versions of Alkindi Sprinkle launch?

Alkindi Sprinkle is a drug marketed by Eton and is included in one NDA. There are three patents protecting this drug.

This drug has fifty patent family members in twenty-three countries.

The generic ingredient in ALKINDI SPRINKLE is hydrocortisone. There are sixty-seven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Alkindi Sprinkle

A generic version of ALKINDI SPRINKLE was approved as hydrocortisone by IMPAX LABS INC on March 30th, 2007.

  Get Started Free

US Patents and Regulatory Information for ALKINDI SPRINKLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eton ALKINDI SPRINKLE hydrocortisone GRANULE;ORAL 213876-001 Sep 29, 2020 RX Yes No   Get Started Free   Get Started Free   Get Started Free
Eton ALKINDI SPRINKLE hydrocortisone GRANULE;ORAL 213876-003 Sep 29, 2020 RX Yes No   Get Started Free   Get Started Free   Get Started Free
Eton ALKINDI SPRINKLE hydrocortisone GRANULE;ORAL 213876-002 Sep 29, 2020 RX Yes No   Get Started Free   Get Started Free   Get Started Free
Eton ALKINDI SPRINKLE hydrocortisone GRANULE;ORAL 213876-004 Sep 29, 2020 RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Eton ALKINDI SPRINKLE hydrocortisone GRANULE;ORAL 213876-003 Sep 29, 2020 RX Yes No   Get Started Free   Get Started Free Y   Get Started Free
Eton ALKINDI SPRINKLE hydrocortisone GRANULE;ORAL 213876-001 Sep 29, 2020 RX Yes No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for ALKINDI SPRINKLE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0809498 SPC/GB10/012 United Kingdom   Get Started Free PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
0809498 10C0038 France   Get Started Free PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.